Drug Policy and the Public Good

Thomas BaborProfessor and Chairman, Department of Community Medicine and Health Care, Health Net, Inc., Endowed Chair in Community Medicine and Public Health, University of Connecticut School of Medicine, Farmington, Connecticut, United States of AmericaJonathan CaulkinsStever University Professor of Operations Research and Public Policy, Carnegie Mellon University, Heinz College, Pittsburgh, Pennsylvania, United States of America Benedikt FischerSenior Scientist, Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Professor, Department of Psychiatry, Institute of Medical Science, and Centre for Criminology and Sociolegal Studies, University of Toronto, Toronto, CanadaDavid FoxcroftProfessor of Community Psychology and Public Health, Oxford Brookes University, Oxford, United KingdomKeith HumphreysResearch Career Scientist, Department of Veteran Affairs; Professor of Psychiatry, Stanford University, Palo Alto, California, United States of AmericaMaría Elena Medina-MoraGeneral Director, National Institute on Psychiatry Ramon de la Fuente Muniz, Mexico City, MexicoIsidore ObotProfessor of Psychology, University of Uyo; Director, Centre for Research and Information on Substance Abuse (CRISA), Uyo, Akwa Ibom State, NigeriaJürgen RehmSenior Scientist and Director, Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Professor and Chair, Addiction Policy, Dalla Lana School of Public Health, University of Toronto, Toronto, CanadaPeter ReuterProfessor, School of Public Policy and Department of Criminology, University of Maryland, College Park, Maryland, United States of America Robin RoomProfessor, School of Population Health, University of Melbourne, Melbourne, Australia; Director, AER Centre for Alcohol Policy Research, Turning Point Alcohol and Drug Centre, Fitzroy, Australia; Professor, Centre for Social Research on Alcohol and Drugs, Stockholm University, Stockholm, SwedenIngeborg RossowResearch Director, Norwegian Institute for Alcohol and Drug Research, Oslo, NorwayJohn StrangProfessor of the Addictions and Director, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom

• Section 1: Introduction1: Framing the issues2: Matters of substanceSection 2: Drug epidemiology and drug markets3: Drug use in global perspective4: Harms associated with illicit drug use5: Illegal markets: the economics and social costs of drug distribution6: The legal market: prescription and diversion of psychopharmaceuticalsSection 3: The evidence base for drug policy: research on strategies and interventions7: Strategies and interventions to reduce drug use and related harm: section overview8: Preventing illicit drug use by young people9: Health and social services for drug users10: Supply control for illegal markets11: Criminalization and decriminalization of drug possession12: Managing psychopharmaceutical drugs under prescription regimesSection 4: The policy arena13: Drug policy and control at the international level14: Legalizing the supply of cannabis15: Treatment systems for drug usersSection 5: Synthesis and conclusions16: Summary and conclusions

I really liked this book ... it is factual and light on opinions, exactly what is needed for this subject. This is the best book I have been asked to review.